Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats
The Journal of Pathology · 2025
DOI: 10.1002/path.6375 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2025. Verfasst von Astrid Van den Branden und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cell Death Signaling Lab, Department of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Vascular Calcification, Lipid Peroxidation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, Bijzonder Onderzoeksfonds UAntwerpen.
Abstract (Originalsprache)
Arterial media calcification is a severe cardiovascular complication commonly manifesting in patients with chronic kidney disease (CKD). Patients with CKD frequently undergo intravenous iron therapy to address iron deficiency. Iron is suggested to be sequestered in vascular cells, potentially leading to oxidative (lipid) stress and cell death, which are recognized as key contributors to arterial calcification. The objective of this study was to investigate the effect of intravenous iron administration on CKD‐induced arterial media calcification. Therefore, adenine‐induced CKD rats were treated intravenously with iron and checked for arterial iron deposition and calcification, as well as for ferritin and lipid peroxidation markers. Additionally, arterial sections from patients with CKD who were dialysis dependent were analyzed for these parameters. This study showed that intravenous iron administration in CKD rats led to arterial iron deposition and a lipid peroxidation signature. CKD‐induced arterial calcification was increased upon iron treatment and correlated with arterial iron accumulation and lipid peroxidation markers. Patients with CKD who were dialysis dependent showed arterial iron accumulation and elevated lipid peroxidation, but a direct correlation with arterial calcification was lacking. Taken together, iron treatment is suggested as a potential contributor to the calcification process, instead of being a predominant factor, thereby emphasizing the complexity of arterial calcification as a multifactorial disease. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Death Signaling Lab, Department of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.
- Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
ORCID-Profile: Astrid Van den Branden, Britt Opdebeeck, Saar Adriaensen, Pieter Evenepoel, Tom Vanden Berghe, Anja Verhulst
Förderung
- Fonds Wetenschappelijk Onderzoek
- Bijzonder Onderzoeksfonds UAntwerpen
Zitieren
APA
Van den Branden, A., Opdebeeck, B., Adriaensen, S., Evenepoel, P., Vanden Berghe, T., & Verhulst, A. (2025). Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats. The Journal of Pathology. https://doi.org/10.1002/path.6375
Vancouver
Van den Branden A, Opdebeeck B, Adriaensen S, Evenepoel P, Vanden Berghe T, Verhulst A. Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats. The Journal of Pathology. 2025. doi:10.1002/path.6375
BibTeX
@article{VandenBranden2025,
author = {Van den Branden, Astrid and Opdebeeck, Britt and Adriaensen, Saar and Evenepoel, Pieter and Vanden Berghe, Tom and Verhulst, Anja},
title = {Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats},
journal = {The Journal of Pathology},
year = {2025},
doi = {10.1002/path.6375}
}
EUVIMED